ERN RARE-LIVER Webinar Series: 18 August 2026 Sex hormonal impact in gender modification on the occur-rence of vascular liver disease

This ERN RARE-LIVER Webinar on 18 August 2026 at 5pm (CEST) will be a webinar from the ERN RARE-LIVER Vascular Liver Diseases Working Group.

Back to overview

Please use this link: https://uke-de.zoom-x.de/j/62903918563?pwd=KjvpaDAGTwa2SFigJqa52noySzaQO0.1

Moderator: Erica Villa (IRCCS Saverio de Bellis)

Speakers:

Case presentation: Salvatore Fasano (Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris France)

Talk 1 Speaker: Aurélie Plessier (Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris France)

Talk 2 Speaker: Marco Senzolo (Azienda Ospedaliera Università di Padova)

Agenda:

Improving our understanding of sex-specific disease mechanisms is essential for developing personalised treatment strategies and achieving optimal therapeutic outcomes

Case presentation: Recurrent portal vein thrombosis in a transgender individual on hormonal therapy

Talk 1: Rare portal hypertension-associated conditions: sex imbalance and modifications with sex hormones

Talk 2: Sex/gender differences in vascular liver disease

Short bios

Erica Villa is a gastroenterologist and hepatologist with longstanding expertise in cirrhosis, portal hypertension, coagulation disorders, portal vein thrombosis, and hepatocellular carcinoma. Her research focuses on translational and clinical studies aimed at improving risk stratification, biomarker-based prediction, and management of patients with chronic liver disease. She has led prospective cohort studies, contributed to international collaborations, and played an active role in guideline development and scientific societies. Her work bridges hemostasis, inflammation, vascular liver disease, and liver cancer, with particular interest in the mechanisms and clinical impact of decompensation, thrombosis, and cancer progression across diverse etiologies and clinical settings.

Salvatore Fasano

Aurélie Plessier is a hepatologist at Beaujon Hospital (AP-HP), Clichy, France, and coordinator of the French Reference Centre for Vascular Liver Diseases and the FILFOIE Rare Liver Disease Network. Her work focuses on vascular liver diseases and portal hypertension She works closely with patient associations and has recently been involved in European research through the LIVES project on patient-reported outcomes (PROs). She contributes to international guidelines, including EASL and Baveno consensus recommendations.

Marco Senzolo